After activated SMARTA cell transfer, the absolute number of endogenous tumor-reactive CD4+and CD8+ T cells (as determined by CD44+PD-1+ (26–28)) increased dramatically (Supplementary Figures 2A, B). This evidence concerns the gene CD8A and neoplasm.